Developing novel diagnostic and therapeutic approaches to advance both animal and human welfare. Using data from patients and animal models of disease, this programme of work aims to develop novel diagnostic and therapeutic approaches to advance both animal and human welfare. A particular area of interest is the development of species-specific monoclonal antibodies for diagnostic and therapeutic purposes.Related newsVitamin D a Predictor of Poor Clinical OutcomesDog study shapes plan to wipe out rabies This article was published on 2024-09-02
